Interdisciplinary Institute for Neuroscience, University of Bordeaux, F-33000 Bordeaux, France.
Cereb Cortex. 2013 Feb;23(2):323-31. doi: 10.1093/cercor/bhs022. Epub 2012 Feb 17.
Progress in understanding the roles of kainate receptors (KARs) in synaptic integration, synaptic networks, and higher brain function has been hampered by the lack of selective pharmacological tools. We have found that UBP310 and related willardiine derivatives, previously characterized as selective GluK1 and GluK3 KAR antagonists, block postsynaptic KARs at hippocampal mossy fiber (MF) CA3 synapses while sparing AMPA and NMDA receptors. We further show that UBP310 is an antagonist of recombinant GluK2/GluK5 receptors, the major population of KARs in the brain. Postsynaptic KAR receptor blockade at MF synapses significantly reduces the sustained depolarization, which builds up during repetitive activity, and impacts on spike transmission mediated by heterosynaptic signals. In addition, KARs present in aberrant MF synapses in the epileptic hippocampus were also blocked by UBP310. Our results support a specific role for postsynaptic KARs in synaptic integration of CA3 pyramidal cells and describe a tool that will be instrumental in understanding the physiopathological role of KARs in the brain.
对 KAR (红藻氨酸受体)在突触整合、突触网络和大脑高级功能中作用的理解进展一直受到缺乏选择性药理学工具的阻碍。我们发现 UBP310 和相关的 willardiine 衍生物,以前被描述为选择性 GluK1 和 GluK3 KAR 拮抗剂,可在海马苔藓纤维(MF)CA3 突触中阻断突触后 KAR,而不影响 AMPA 和 NMDA 受体。我们进一步表明,UBP310 是重组 GluK2/GluK5 受体的拮抗剂,该受体是大脑中 KAR 的主要群体。MF 突触处的突触后 KAR 受体阻断可显著减少在重复活动期间积累的持续去极化,并影响由异突触信号介导的尖峰传递。此外,在癫痫海马体中异常 MF 突触中的 KAR 也被 UBP310 阻断。我们的结果支持 CA3 锥体神经元突触整合中突触后 KAR 的特定作用,并描述了一种工具,该工具将有助于理解 KAR 在大脑中的生理病理作用。